COMMUNIQUÉS West-GlobeNewswire

-
ObsEva SA Announces $60.0 Million Private Placement with Existing and New Investors
10/10/2017 -
The IPO of Terveystalo Plc has been oversubscribed and the listing will be completed as planned
10/10/2017 -
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections
10/10/2017 -
Apricus Biosciences to Present at the 2017 BIO Investor Forum
10/10/2017 -
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
10/10/2017 -
Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO)
10/10/2017 -
Solon Eiendom ASA : Primary insider notification
10/10/2017 -
Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC
10/10/2017 -
Akcea Therapeutics' Volanesorsen Receives Promising Innovative Medicine (PIM) Status for the Treatment of Familial Chylomicronaemia Syndrome (FCS)
10/10/2017 -
Nicox et pSivida : accord de collaboration stratégique en vue du développement d'un médicament à libération prolongée pour réduire la pression intraoculaire chez les patients atteints de glaucome
10/10/2017 -
Nicox and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular pressure in patients with glaucoma
10/10/2017 -
MITHRA'S MARKETING AUTHORIZATION APPLICATION FOR TIBELIA® ACCEPTED BY HEALTH CANADA
10/10/2017 -
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
10/10/2017 -
Biocartis Group NV: Disclosure of outstanding voting securities
10/10/2017 -
Medtronic to Establish Innovation Center in Chengdu
10/10/2017 -
IBA SA : IBA signe un accord de collaboration mondial avec VINCI Construction
10/10/2017 -
IBA SA : IBA signs global construction collaboration with VINCI Construction
10/10/2017 -
Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team
09/10/2017 -
CORRECTION: Össur hf: Q3 2017 Results - Conference call Wednesday 25 October at 9:00 CET
09/10/2017
Pages